Research Journal of Medical Sciences
ISSN: Online 1993-6095ISSN: Print 1815-9346
Abstract
Dry eye syndrome (DES) is a prevalent condition among postmenopausal women, often resulting in significant discomfort and impairment in quality of life. This study aims to assess the prevalence and severity of DES in this demographic, examining the potential protective effects of hormone replacement therapy (HRT). A cross‐sectional study was conducted with 280 postmenopausal women recruited from a tertiary care center. Participants were evaluated for symptoms and signs of DES using a combination of patient‐reported symptoms, Schirmer's test and tear film break‐up time (TBUT). The impact of HRT on the incidence of DES was also analyzed. Of the participants, 58.6% were diagnosed with dry eye syndrome. The severity of symptoms was categorized as none (15.7%), mild (27.9%), moderate (40.0%) and severe (16.4%). Women on HRT exhibited a significantly lower incidence of DES (19.3%) compared to those not on HRT (39.3%). Statistical analysis revealed significant differences in the prevalence and severity of DES among the study population (Chi‐square test=8.45, p<0.05). The high prevalence of dry eye syndrome in postmenopausal women underscores the need for targeted screening and management strategies in this group. Hormone replacement therapy may offer protective benefits against DES, suggesting a potential therapeutic avenue. Further longitudinal studies are needed to explore the causative factors and long‐term effects of hormonal treatments on DES.
How to cite this article:
K. Kavya Lahari, Mohammed Azhar Chisti, Azeemunisa Mohammed and A. Venkata Satish. Assessment of Dry Eye Syndrome in Post Menopausal Women.
DOI: https://doi.org/10.36478/10.36478/makrjms.2024.11.443.447
URL: https://www.makhillpublications.co/view-article/1815-9346/10.36478/makrjms.2024.11.443.447